News

Chemiesynth (Vapi) Limited informed the Bombay Stock Exchange that details of securities dematerialized/rematerialized during the quarter ended September 30, 2026, have been furnished to stock exchanges as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, with a confirmation certificate from Purva Sharegistry (I) Private Limited dated October 1, 2026.

Chemiesynth (Vapi) Limited informed the BSE Limited that the trading window for dealing in the company`s securities will be closed from October 1, 2026, until 48 hours after the announcement of the unaudited financial results for the half year ended September 30, 2026, with a board meeting to approve the financial statements scheduled on or before November 14, 2026.

Chemiesynth (Vapi) will hold a meeting of the Board of Directors of the Company on 12 August 2026.

Net profit of Chemiesynth (Vapi) rose 215.79% to Rs 0.60 crore in the quarter ended March 2026 as against Rs 0.19 crore during the previous quarter ended March 2025. Sales declined 17.66% to Rs 5.50 crore in the quarter ended March 2026 as against Rs 6.68 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 0.99 crore in the year ended March 2026 as against net loss of Rs 0.11 crore during the previous year ended March 2025. Sales rose 13.50% to Rs 21.44 crore in the year ended March 2026 as against Rs 18.89 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales5.506.68 -18 21.4418.89 14 OPM %19.0912.13 -6.3011.54 - PBDT0.840.62 35 0.371.39 -73 PBT0.540.29 86 -1.05-0.01 -10400 NP0.600.19 216 -0.99-0.11 -800 Powered by Capital Market - Live News

Chemiesynth (Vapi) will hold a meeting of the Board of Directors of the Company on 27 May 2026.